Rosalind Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-100,000
Closed -$52K 41
2024
Q4
$52K Buy
+100,000
New +$52K 0.03% 28